Children with HIV infection with antiretroviral therapy HIV infected children antiretroviral L.plantarum IS-
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Children 5-18 years old HIV infected (based on WHO criteria), with an absolute CD4+ T cell count ≥ 350 cells/mm3 Receiving antiretroviral therapy, for a minimum 6 months prior to inclusion
Exclusion criteria
Exclusion criteria: Infected HIV children that withdrew antiretroviral therapy Receiving probiotic supplementation 2 weeks before the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Serum CD4+ T cell count After 6 weeks of treatment Flow cytometry (BD FACSCalibur) with BD Reagent,Serum CD8+ T cell count After 6 weeks of treatment Flow cytometry (BD FACSCalibur) with BD Reagent,Fecal sIgA level After 6 weeks of treatment Solid phase direct ELISA sandwich method from Calbiotech ,T helper 1 based on interferon-gamma After 6 weeks of treatment ELISA method using blood sample,T helper 2 based on IL-4 After 6 weeks of treatment ELISA method using blood sample,T helper 17 based on IL-17 After 6 weeks of treatment ELISA method using blood sample,Treg based on TGF-beta ELISA method using blood sample ELISA method using blood sample,Blood lipopolysaccaride After 6 weeks of treatment Limulus Amebocyte Lysate ELISA method using blood sample,Fecal calprotectin After 6 weeks of treatment ELISA method using feces sample | — |
Secondary
| Measure | Time frame |
|---|---|
| N/A N/A N/A | — |
Countries
Indonesia
Contacts
Universitas Airlangga